ArticleMethodsX2026
Engineering vascularized 3D tissues: An optimized seeding protocol for collagen-based scaffolds.
Article in MethodsX, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The objective of this work was to optimize endothelial cell seeding for 3-dimensional (3D) culture in collagen-based scaffolds to conduct physiologically relevant in vitro studies. Endothelial cells are highly sensitive to their mechanical environment making 2D experiments on polystyrene difficult to translate to in vivo conditions. Therefore, conducting 3D endothelial experiments in collagen scaffolds are critical to elucidate more physiologically accurate responses. However, researchers employ a wide range of scaffold fabrication methods and endothelial cell seeding protocols leading to varying levels of vascularization and interconnectedness between endothelial cells making results difficult to interpret or compare across studies. Here, we propose an optimized endothelial cell seeding protocol using a commercially available collagen scaffold that results in a reproducibly, well-connected vascular network uniformly seeded throughout the entire scaffold enabling researchers to more reliably vascularize collagen scaffolds. We found that pre-saturating scaffolds, seeding from opposing sides of the scaffold, using 600,000 cells per 100 uL of media, and incubating for 120 h after seeding yielded the most uniform and interconnected vascular networks throughout the collagen scaffold. Our method provides: An optimized scaffold pre-seeding technique, cell density, and incubation time. A seeding strategy to ensure consistently vascularized collagen scaffolds with interconnected networks and uniform seeding throughout a commercially available collagen scaffold.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.